论文部分内容阅读
The standard antiviral therapy for dialysis patients infected with hepatitis C virus(HCV)is(pegylated)interferon monotherapy,but its efficacy is insufficient.Oral direct-acting antiviral agents(DAAs)have recently been developed for chronic hepatitis C pat